We are defining how host-pathogen interactions influence outcomes to improve preventions & cures.

We lack effective treatments and preventions for many of the most challenging infectious diseases, many of which disproportionately impact those in low- and middle-income countries or traditionally marginalized communities. By developing and applying cutting edge tools to examine how cells dynamically alter their states, individually and collectively, during disease and/or its resolution in acute and chronic infections with partners around the world, we seek to uncover cellular and molecular features of pathogen control or pathology to potentiate or counteract, respectively.

Our goal is to understand the drivers of common host responses to distinct perturbations, as well as the impact of intervention, to help guide next-generation preventions and cures.

Highlights

Variants and vaccines impact nasal immunity over three waves of SARS-CoV-2

Walsh et al., Nature Immunology, 2025

Viral variant and host vaccination status impact infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), yet how these factors shift cellular responses in the human nasal mucosa remains uncharacterized. We performed single-cell RNA sequencing (scRNA-seq) on nasopharyngeal swabs from vaccinated and unvaccinated adults with acute Delta and Omicron SARS-CoV-2 infections and integrated with data from acute infections with ancestral SARS-CoV-2. Patients with Delta and Omicron exhibited greater similarity in nasal cell composition driven by myeloid, T cell and SARS-CoV-2hi cell subsets, which was distinct from that of ancestral cases. Delta-infected […]